A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

NCT07276724 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

786

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Asthma

Interventions

DRUG: GB-0895
DRUG: Placebo

Sponsor

Generate Biomedicines